The Trouble with Cancer Screening
Tests for cancer often lead to more confusion than clarity. Here’s how to understand them. The post The Trouble with Cancer Screening appeared first on Nautilus .
Doctors Rahul and Jonathan experienced a typical overcast morning in the San Francisco Bay area as they both headed to work. Rahul, a pediatrician, was notified of a medical test result by a phone push notification while strolling through the parking lot. He had recently seen his doctor for a routine checkup where a bundle of tests was ordered algorithmically by his doctor, including blood count, electrolytes, and cholesterol levels, all of which were normal.
Rahul opened his email and searched for information about a slightly elevated PSA test, which is a biomarker of potential prostate cancer. He wondered whether he needed an invasive biopsy or if he should ignore the result. Despite repeated tests showing the same result, Rahul was still uncertain about his diagnosis.
Medical consensus once recommended that every man over 50, like Rahul, should have the PSA test. However, this recommendation has since been softened, with some experts suggesting that regular screening be dropped altogether. The potential harms of treatment might outweigh the benefits, as prostate cancer often grows slowly and may never cause a problem.
Rahul's doctor did not discuss these facts with him, and he was left to make his own decisions about whether to undergo an invasive biopsy or ignore the result. The uncertainty and frustration of not having a clear answer to his diagnosis was overwhelming. The whole experience felt pointless, and Rahul questioned whether patients could ever truly feel certain about their health.
Written by urgent.news from Nautilus's reporting — not their text. Machine-written — it may contain errors, so check the original before relying on it.
